Global Celiac Diseases Drugs Market to Grow by Over $540 Million During 2020-2024 | North America to Dominate With 58% Market Share | Technavio

Global Celiac Diseases Drugs Market to Grow by Over $540 Million During 2020-2024 | North America to Dominate With 58% Market Share | Technavio




Global Celiac Diseases Drugs Market to Grow by Over $540 Million During 2020-2024 | North America to Dominate With 58% Market Share | Technavio

LONDON–(BUSINESS WIRE)–#CeliacDiseasesDrugs–The celiac diseases drugs market is poised to grow by USD 541.29 million during 2020-2024 progressing at a CAGR of over 19% during the forecast period.


For a More Detailed Analysis, Get a Free Sample Report Delivered Instantly

The report on the celiac diseases drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by higher consumption of gluten-containing food.

The celiac diseases drugs market analysis includes the type and geography landscape. This study identifies the increasing prevalence of celiac disease as one of the prime reasons that will drive the celiac diseases drugs market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

The celiac diseases drugs market covers the following areas:

Celiac Diseases Drugs Market Sizing

Celiac Diseases Drugs Market Forecast

Celiac Diseases Drugs Market Analysis

Develop Smart Strategies for Your Business: Get a Free Sample Report Now!

Companies Mentioned

  • Amgen Inc.
  • AMYRA Biotech AG
  • BioLineRx Ltd.
  • Bristol-Myers Squibb Co.
  • Calypso Biotech
  • GlaxoSmithKline Plc
  • Immunogenics LLC
  • Johnson & Johnson
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd. 

Related Reports on Health Care Include:

Global Actinic Keratosis Drugs Market – Global actinic keratosis drugs market segmentation by drug class (nucleoside metabolic inhibitors, immunomodulators, photosensitizers, and NSAIDs) and geography (North America, APAC, Europe, and ROW). Click Here to Get an Exclusive Free Sample Report

Global Antibiotics Market – Global antibiotics market segmentation by application (antibiotics for human use and antibiotics for veterinary use), product (broad-spectrum antibiotics and narrow-spectrum antibiotics), drug origin (natural, semi-synthetic, and synthetic), action mechanism (bacteriostatic, and bactericidal), and geography (North America, APAC, Europe, South America, and MEA). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Therapy type

  • Market segments
  • Comparison by therapy type
  • First line of treatment – Market size and forecast 2019-2024
  • Second line of treatment – Market size and forecast 2019-2024
  • Market opportunity by therapy type

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • AMYRA Biotech AG
  • BioLineRx Ltd.
  • Bristol-Myers Squibb Co.
  • Calypso Biotech
  • GlaxoSmithKline Plc
  • Immunogenics LLC
  • Johnson & Johnson
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com
Website: www.technavio.com/